Search

Search Constraints

You searched for: Author/Creator Inwards, David

Search Results

1. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. (15th March 2016)

2. A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy. Issue 5 (22nd March 2017)

3. Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia. Issue 3 (31st December 2019)

4. Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes. (29th August 2019)

5. Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress. (6th November 2014)

6. Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. Issue 10 (12th February 2020)

7. Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia. Issue 8 (22nd May 2021)

8. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure. Issue 12 (12th April 2018)

9. Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience. Issue 3 (1st January 2023)

10. Central nervous system involvement by mantle cell lymphoma. Issue 2 (28th January 2023)